PLCG2 and B-cell chronic lymphocytic leukemia: The cSH2 mutation Arg665Trp (PLCγ2) occurs in the context of resistance to the Bruton’s tyrosine kinase inhibitor ibrutinib used in chronic lymphocytic leukemia (15).